Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naoshuantong Capsule registry study in ischemic stroke
ChiCTR1900025053Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of naoshuantong in ischemic stroke, sponsored by Beijing University of Chinese Medicine. Primary endpoints: Degree of disability, Degree of neurological impairment and 4 more. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
naoshuantong
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1900025053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025053.